Doug Kerr, an officer of Dyne Therapeutics, proposes to sell 5000 common shares valued at $121745.00. The planned transaction matters to investors because it identifies a proposed insider sale, while the record also lists restricted-stock-unit issuances and earlier common-stock transactions involving Kerr.
Key Highlights
- The record lists 11,875 common shares through restricted stock units dated 09/03/2026.
- The record lists 3000 common shares through restricted stock units dated 09/04/2026.
- Earlier listed transactions involved 887 shares for $16,263 and 1556 shares for $40,892.
Dyne Therapeutics, Inc. (NASDAQ: DYN) officer Doug Kerr proposed selling common stock listed at $121,745 on 09/04/2026. The proposed transaction covers 5000 common shares and identifies Stifel Nicolaus & Company Inc as the broker.
5000-Share Sale Kerr
The record lists 186,746,431 shares outstanding and identifies Nasdaq as the market for the common stock. James Weimer signed for Stifel Nicolaus & Company Inc as attorney-in-fact for Kerr. The broker’s address is 501 N Broadway, St. Louis, MO 63,102. The same record lists restricted-stock-unit activity involving Kerr. The filing shows 11,875 common shares dated 09/03/2026 and 3000 common shares dated 09/04/2026, each connected with issuer Equity compensation.
Kerr’s Earlier Stock Transactions Kerr’s
listed common-stock transactions include 887 shares dated 06/16/2026 with a stated amount of $16,263. Another entry records 1556 shares dated 08/13/2026 with a stated amount of $40,892.
FAQs
Q: What is Doug Kerr proposing to sell in Dyne Therapeutics stock?
A: Dyne Therapeutics officer Doug Kerr proposes selling 5000 common shares. The listed amount for the proposed insider sale is $121,745 through Stifel Nicolaus & Company Inc.
Q: What restricted stock units are listed for Dyne Therapeutics?
A: The record lists 11,875 common shares dated 09/03/2026 and 3000 common shares dated 09/04/2026. Both entries are connected with issuer equity compensation.
Q: What earlier Dyne Therapeutics stock transactions involved Kerr?
A: The filing lists an earlier entry for 887 common shares dated 06/16/2026, with a stated amount of $16,263. It also lists 1556 shares dated 08/13/2026, with a stated amount of $40,892.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.